Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Drugs. 2018 Jul;78(11):1113–1132. doi: 10.1007/s40265-018-0946-y

Table 3.

Mechanism of anti-obesity drugs acting in the central nervous system

Drug name Mechanism
Phentermine, diethylpropion, benzphetamine, and phendimetrazine norepinephrine release with minor dopamine release
Bupropion/naltrexone Stimulates dopamine and POMC neurons and blocks inhibitory feedback to mu opioid receptor on POMC neurons
Topiramate/phentermine norepinephrine release, GABA modulation, voltage-gated ion channel modulation, inhibition of AMPA/kainite excitatory glutamate receptors and inhibition of carbonic anhydrase
Lorcaserin Serotonin 2C receptor agonist
Lorcaserin-ER Serotonin 2C receptor agonist
Liraglutide Glucagon-like peptide-1 agonist
Drugs in Phase III
Tesofensine Reuptake inhibitor of serotonin, norepinephrine and dopamine

ER = Extended Release; POMC = Proopiomelanocortin; GABA = Gamma-Aminobutyric Acid; AMPA = α- amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid